Robert A. Graf
Robert A. Graf
Send Message
Robert A. Graf
Stop FollowingRobert A. Graf
ABOUT
Robert Graf is an independent investor entrepreneur, and educator with a 20+ year academic background in pharmaceutical sciences and pharmacology. He focuses his attention on index options, top performing small cap companies, commodities, and is a student of price action. He is founder, President, and Chief Broker of Golden Gate Commercial Properties where he focuses on building value, creating and retaining wealth with a combination of paper and hard assets.
Robert graduated from the University of California at Berkeley (AB) and from the University of Hawai'i in Honolulu (Ph.D). As an educator, he has spent the last ten years as assistant and associate professor of pharmaceutical sciences teaching about ...More clinical trials as well as all major drug classes in use today. Dr. Graf has published in international journals, and is best known for his contributions to the field of crustacean neuronal cell culture and founding the circuit buffer theory of Alzheimer's Disease.
Robert graduated from the University of California at Berkeley (AB) and from the University of Hawai'i in Honolulu (Ph.D). As an educator, he has spent the last ten years as assistant and associate professor of pharmaceutical sciences teaching about ...More clinical trials as well as all major drug classes in use today. Dr. Graf has published in international journals, and is best known for his contributions to the field of crustacean neuronal cell culture and founding the circuit buffer theory of Alzheimer's Disease.
SNAPSHOT
- Description: Professor. Trading frequency: Daily
- Interests: Dividend stock ideas & income, Options, REITs, Retirement savings, Stocks - long, Stocks - short, Tech stocks
COMPANY
Currently, there is no company profile for Robert A. Graf.
BLOG
Currently, there are no blog details for Robert A. Graf.
Book
Currently, there are no book details for Robert A. Graf.
LATEST STOCKTALK
more »
Following Allergan (AGN) on this chatter of an Abbott Labs $100/share offer. Didn't Cramer suggest that on-air a few weeks ago?
Nov 15, 2010
Latest Comments
more »
- I hope you weren't heavy in... on Five Reasons to Sell
- I noticed the increased act... on The market's gains last week had the scent of d...
- It is going to be difficult... on Five Reasons to Sell
- FYI, for another article th... on Five Reasons to Sell
- Hirendu -- I think trading ... on S&P's Most Overbought Close in More Than a Year
Latest comments on Robert A.'s Articles
LATEST ARTICLES & INSTAPOSTS
more »
